TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 19563331

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Non-activated laser (control)
Number of subjects: 10
Study: 17538805

Group type: EXPERIMENTAL
Intervention: 1% terbinafine emulsion gel
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: 3% terbinafine emulsion gel
Number of subjects: 84

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 84
Study: 15003135

Group type: EXPERIMENTAL
Intervention: Lifestyle interventions including nutritional advice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current schemes for evaluating evidence
Number of subjects: 0
Study: 11422706

Group type: EXPERIMENTAL
Intervention: 23 h stay (overnight) in a general surgical ward
Number of subjects: 28

Group type: COMPARATOR
Intervention: Day procedure unit (DPU) stay
Number of subjects: 28
Study: 9891541

Group type: EXPERIMENTAL
Intervention: Induction platinum based chemotherapy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Concurrent chemotherapy
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: p53 positive cells
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: bcl-2 positive cells
Number of subjects: 76
Study: 8006266

Group type: EXPERIMENTAL
Intervention: Active compression-decompression cardiopulmonary resuscitation
Number of subjects: 53

Group type: COMPARATOR
Intervention: Standard manual cardiopulmonary resuscitation
Number of subjects: 53
Study: 2642536

Group type: EXPERIMENTAL
Intervention: Metoclopramide plus dexamethasone
Number of subjects: 91

Group type: EXPERIMENTAL
Intervention: Dexamethasone alone
Number of subjects: 91

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 91
Study: 4827463

Group type: EXPERIMENTAL
Intervention: Diazepam (Valium), 20 mg daily for at least 5 consecutive days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 29411269

Group type: EXPERIMENTAL
Intervention: Lenalid® 25 mg tablet (test formulation)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Revlimid® 25 mg capsule (reference formulation)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Both formulations
Number of subjects: 42
Study: 27543211

Group type: EXPERIMENTAL
Intervention: Topical corticosteroid (TCS) alone
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Topical corticosteroid (TCS) + dilute bleach bath
Number of subjects: 21

Group type: COMPARATOR
Intervention: Control (healthy children)
Number of subjects: 21
Study: 25082395

Group type: EXPERIMENTAL
Intervention: Lacosamide 400 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lacosamide 600 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 21923279

Group type: EXPERIMENTAL
Intervention: Intraoperative intravitreal pegaptanib injection, n=250
Number of subjects: 500

Group type: COMPARATOR
Intervention: Control group (no pegaptanib), n=250
Number of subjects: 500
Study: 20847623

Group type: EXPERIMENTAL
Intervention: Anorectal manometry
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Endoanal ultrasonography
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (score of 2 or less on Pescatori incontinence scale)
Number of subjects: 108
Study: 18077056

Group type: EXPERIMENTAL
Intervention: vitamin/mineral/guaraná supplement
Number of subjects: 129

Group type: COMPARATOR
Intervention: placebo drink
Number of subjects: 129
Study: 15068851

Group type: EXPERIMENTAL
Intervention: Therapeutic immunizations with recombinant gp160
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunizations with HIV DNA during HAART treatment
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Immunization with gp160
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-term HAART treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Single structured therapy interruption (STI)
Number of subjects: 0
Study: 11176590

Group type: EXPERIMENTAL
Intervention: Ofloxacin (Floxin otic)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral amoxicillin/clavulanate (Augmentin)
Number of subjects: 0
Study: 9699891

Group type: EXPERIMENTAL
Intervention: Gemfibrozil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 7916278

Group type: EXPERIMENTAL
Intervention: Inactivated MUKC vaccine (3 doses)
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: Inactivated MUKC vaccine (3 doses, different procedures)
Number of subjects: 2479

Group type: EXPERIMENTAL
Intervention: Inactivated MUKC vaccine (secondary immunization)
Number of subjects: 2479
Study: 2556518

Group type: EXPERIMENTAL
Intervention: Educational booklet on back pain
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 16301238

Group type: COMPARATOR
Intervention: 225 mg ropivacaine (7.5 mg/mL) alone (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 225 mg ropivacaine combined with 75 mug clonidine (clonidine group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clonidine group
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 31204605

Group type: EXPERIMENTAL
Intervention: Occlusal splints (OS; n= 24)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Manual therapy (MT; n= 21)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Counseling (C; n= 19)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Occlusal splints associated with counseling (OSC; n= 25)
Number of subjects: 89
Study: 31932513

Group type: EXPERIMENTAL
Intervention: Folic acid 0.8 mg with enalapril 10 mg
Number of subjects: 20702

Group type: COMPARATOR
Intervention: Enalapril 10 mg alone
Number of subjects: 20702

Group type: EXPERIMENTAL
Intervention: Folic acid treatment
Number of subjects: 20702
Study: 30378521

Group type: EXPERIMENTAL
Intervention: Autonomy support practices
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Coercive control and indulgent feeding practices
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Negative role modelling
Number of subjects: 133
Study: 28643321

Group type: EXPERIMENTAL
Intervention: Global End-Diastolic Volume (GEDV) monitoring
Number of subjects: 74

Group type: COMPARATOR
Intervention: Central Venous Pressure (CVP) monitoring
Number of subjects: 74
Study: 26550817

Group type: EXPERIMENTAL
Intervention: Intra-articular injection of hyaluronic acid (HA) + oral viscosupplementation (IA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Intra-articular injection of hyaluronic acid (HA) only
Number of subjects: 100
Study: 22887343

Group type: EXPERIMENTAL
Intervention: 200 µg selenium (N=234)
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: 400 µg selenium (N=233)
Number of subjects: 699

Group type: COMPARATOR
Intervention: Placebo (N=232)
Number of subjects: 699
Study: 21489720

Group type: EXPERIMENTAL
Intervention: Woven polyglycolic acid conduit
Number of subjects: 42

Group type: COMPARATOR
Intervention: Autogenous vein
Number of subjects: 42
Study: 19493391

Group type: EXPERIMENTAL
Intervention: Clopidogrel 150 mg
Number of subjects: 813

Group type: COMPARATOR
Intervention: Clopidogrel 75 mg
Number of subjects: 813
Study: 16202498

Group type: EXPERIMENTAL
Intervention: Standardized composite resin crown (SRCC) with ferrule (2 mm), no post
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Standardized composite resin crown (SRCC) with ferrule and glass fiber post
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Standardized composite resin crown (SRCC) with ferrule and zirconium post
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Standardized composite resin crown (SRCC) with ferrule and cast gold post
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Root-canal-treated with composite resin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Untreated teeth
Number of subjects: 48
Study: 15023883

Group type: EXPERIMENTAL
Intervention: Systolic blood pressure (SBP)
Number of subjects: 5218

Group type: EXPERIMENTAL
Intervention: Diastolic blood pressure, mean arterial pressure, and pulse pressure
Number of subjects: 5218

Group type: COMPARATOR
Intervention: Antihypertensive medication use
Number of subjects: 5218
Study: 11304594

Group type: EXPERIMENTAL
Intervention: 0-polydioxanone
Number of subjects: 20

Group type: COMPARATOR
Intervention: 2-0 nylon
Number of subjects: 20
Study: 9266229

Group type: EXPERIMENTAL
Intervention: Home flow test (HFT)
Number of subjects: 172
Study: 8390508

Group type: EXPERIMENTAL
Intervention: Candoxatril 25 mg every 12 h for 5 days
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Candoxatril 200 mg every 12 h for 5 days
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 3824009

Group type: EXPERIMENTAL
Intervention: Incidental appendectomy
Number of subjects: 100

Group type: COMPARATOR
Intervention: No appendectomy
Number of subjects: 100
Study: 30328014

Group type: EXPERIMENTAL
Intervention: 12-week aerobic exercise program
Number of subjects: 70
Study: 27994257

Group type: EXPERIMENTAL
Intervention: Allogeneic blood transfusion (n = 8)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Autologous blood transfusion (n = 25)
Number of subjects: 50
Study: 24660827

Group type: EXPERIMENTAL
Intervention: BAK-preserved artificial tears
Number of subjects: 44

Group type: COMPARATOR
Intervention: Preservative-free artificial tears
Number of subjects: 44
Study: 22726593

Group type: EXPERIMENTAL
Intervention: AZD8848 (30-100 μg)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: AZD8848 (30 and 60 μg)
Number of subjects: 86

Group type: COMPARATOR
Intervention: AZD8848 (0.3-600 μg)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: AZD8848
Number of subjects: 86
Study: 20147603

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Rosuvastatin 10 mg
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Atorvastatin/Ezetimibe 5 mg/5 mg
Number of subjects: 90

Group type: COMPARATOR
Intervention: Atorvastatin 20 mg, Rosuvastatin 10 mg, Atorvastatin/Ezetimibe 5 mg/5 mg
Number of subjects: 90
Study: 18305126

Group type: EXPERIMENTAL
Intervention: Tadalafil 40 mg once daily for 10 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Bosentan 125 mg twice daily for 10 days
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Combination of tadalafil and bosentan for 10 days
Number of subjects: 15
Study: 14738561

Group type: EXPERIMENTAL
Intervention: Adefovir dipivoxil (ADV) therapy
Number of subjects: 22
Study: 11480308

Group type: EXPERIMENTAL
Intervention: Self-administered questionnaire (SAQ)
Number of subjects: 601

Group type: COMPARATOR
Intervention: Face-to-face (FTF) interview
Number of subjects: 601
Study: 9333281

Group type: EXPERIMENTAL
Intervention: Nylon sutures
Number of subjects: 50

Group type: COMPARATOR
Intervention: Surgical staplers
Number of subjects: 50
Study: 8432223

Group type: EXPERIMENTAL
Intervention: Acarbose 25 mg powdered, 3 times a day with meals for 3 months
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo, 3 times a day with meals for 3 months
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Acarbose 25 mg powdered, 3 times a day with meals
Number of subjects: 6
Study: 3829440

Group type: EXPERIMENTAL
Intervention: S-carboxymethylcysteine (2.25 g per day for 7 days)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31791364

Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Nutrition
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Exercise plus Nutrition (Combination)
Number of subjects: 319

Group type: COMPARATOR
Intervention: Control
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Exercise, Nutrition, and Combination groups
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Nutrition group
Number of subjects: 319
Study: 30320657

Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation (2 drops placed 15 to 20 cm away from the pillow, 30 minutes before bed for 1 week)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Lavender oil inhalation
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 34
Study: 26606329

Group type: COMPARATOR
Intervention: Standard-of-care hormone therapy (HT) alone
Number of subjects: 721

Group type: EXPERIMENTAL
Intervention: Planned use of radiotherapy (RT)
Number of subjects: 721
Study: 24360138

Group type: EXPERIMENTAL
Intervention: Collaborative care
Number of subjects: 259

Group type: COMPARATOR
Intervention: Antidepressant medication
Number of subjects: 259
Study: 22364552

Group type: EXPERIMENTAL
Intervention: Better air quality (median CO₂ level 1045 ppm)
Number of subjects: 417

Group type: COMPARATOR
Intervention: Worse air quality (median CO₂ level 2115 ppm)
Number of subjects: 417
Study: 19514069

Group type: EXPERIMENTAL
Intervention: Multidimensional Fatigue Inventory (MFI)
Number of subjects: 153

Group type: EXPERIMENTAL
Intervention: Multidimensional Fatigue Inventory (MFI) after controlling for depression
Number of subjects: 153
Study: 17215186

Group type: EXPERIMENTAL
Intervention: Oral vitamin B12 supplementation (500 microg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no vitamin B12 supplementation)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Green leafy vegetables (100 g every alternate day)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-dose per oral vitamin B12 supplementation
Number of subjects: 42

Group type: COMPARATOR
Intervention: Vibration sensory threshold
Number of subjects: 42
Study: 15094145

Group type: EXPERIMENTAL
Intervention: Force sense (contralateral force sense reproduction)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Joint reposition sense
Number of subjects: 40
Study: 11014400

Group type: EXPERIMENTAL
Intervention: Treatment Group 1 (acupuncture distal to tourniquet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Treatment Group 2 (acupuncture proximal to tourniquet)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Placebo Group 1 (sham acupuncture on nonacupuncture points)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Placebo Group 2 (sham acupuncture on acupuncture points)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 60
Study: 9306087

Group type: EXPERIMENTAL
Intervention: beta-glucan-rich oat bran
Number of subjects: 36

Group type: COMPARATOR
Intervention: wheat bran
Number of subjects: 36
Study: 8317404

Group type: EXPERIMENTAL
Intervention: Intravenous ketorolac tromethamine (KT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 3728375

Group type: EXPERIMENTAL
Intervention: Mixed beam (neutron/photon) radiotherapy
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Fast neutron radiotherapy
Number of subjects: 102

Group type: COMPARATOR
Intervention: Conventional radiotherapy (photon)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: All arms (mixed beam, neutrons, photons)
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Neutron and mixed beam arms
Number of subjects: 102
Study: 30033064

Group type: COMPARATOR
Intervention: High-dose dexamethasone (20 mg) and 2 injections of normal saline (group B)
Number of subjects: 182

Group type: COMPARATOR
Intervention: High-dose dexamethasone (20 mg) and 2 injections of low-dose (10 mg) dexamethasone (group C)
Number of subjects: 182

Group type: COMPARATOR
Intervention: Normal saline (group A)
Number of subjects: 182
Study: 27028537

Group type: EXPERIMENTAL
Intervention: Squatting position using bars
Number of subjects: 102

Group type: COMPARATOR
Intervention: Supine position modified to 45 degree of semi-fowler
Number of subjects: 102
Study: 25633755

Group type: EXPERIMENTAL
Intervention: Vitamin E infused highly cross-linked polyethylene (E-poly™) with 32 mm heads
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Vitamin E infused highly cross-linked polyethylene (E-poly™) with 36 mm heads
Number of subjects: 50

Group type: COMPARATOR
Intervention: Comparison of 32 mm and 36 mm heads
Number of subjects: 50
Study: 23228033

Group type: EXPERIMENTAL
Intervention: Patients with clinical‐radiological severity mismatch (NIHSS score ≥ 10 and infarct volume <20 cc)
Number of subjects: 277

Group type: COMPARATOR
Intervention: Patients with NIHSS score ≥ 10 and infarct volume ≥ 20 cc
Number of subjects: 277
Study: 21942462

Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users (low adherence)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users (medium adherence)
Number of subjects: 832

Group type: EXPERIMENTAL
Intervention: Tobramycin solution for inhalation (TSI) users (high adherence)
Number of subjects: 832

Group type: COMPARATOR
Intervention: Non-users of TSI
Number of subjects: 832
Study: 18292412

Group type: EXPERIMENTAL
Intervention: Routine management supplemented by an active underbody forced-air system (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine thermal management (fluid warming and passive insulation, n = 30)
Number of subjects: 60
Study: 16449523

Group type: EXPERIMENTAL
Intervention: R-CHOP
Number of subjects: 199

Group type: COMPARATOR
Intervention: CHOP
Number of subjects: 199
Study: 14626184

Group type: EXPERIMENTAL
Intervention: Tongnao Huoluo acupuncture (TNHLA) therapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Immediate thrombolysis by intravenously given urokinase 12 million units
Number of subjects: 0

Group type: COMPARATOR
Intervention: Simple body acupuncture
Number of subjects: 0

Group type: COMPARATOR
Intervention: Intravenous dripping of normal saline (placebo)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TNHLA
Number of subjects: 0

Group type: COMPARATOR
Intervention: Thrombolysis
Number of subjects: 0
Study: 10607320

Group type: EXPERIMENTAL
Intervention: 0.1% isotretinoin
Number of subjects: 800

Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 800
Study: 9106870

Group type: EXPERIMENTAL
Intervention: Child dentifrice (CD)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Adult dentifrice (AD)
Number of subjects: 50
Study: 8427721

Group type: EXPERIMENTAL
Intervention: Ciprofloxacin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Norfloxacin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fluoroquinolones (general)
Number of subjects: 0
Study: 30449719

Group type: EXPERIMENTAL
Intervention: Bevacizumab 7.5 mg/kg every 3 weeks for 6 cycles followed by single-agent bevacizumab for 12 further cycles (total duration 12 months)
Number of subjects: 1160

Group type: COMPARATOR
Intervention: Carboplatin and paclitaxel alone
Number of subjects: 1160

Group type: EXPERIMENTAL
Intervention: Carboplatin and paclitaxel with bevacizumab
Number of subjects: 1160
Study: 27813617

Group type: EXPERIMENTAL
Intervention: 99mTc‐MIBI scintigraphy (washout technique)
Number of subjects: 40
Study: 27639625

Group type: EXPERIMENTAL
Intervention: High-pitch computed tomography (HPCT) under free breathing (FB)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard-pitch CT (SPCT) under breath-hold (BH)
Number of subjects: 100
Study: 25164872

Group type: EXPERIMENTAL
Intervention: Exogenous surfactant (200 mg/kg poractant alfa) via the Hobart method
Number of subjects: 606

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 606
Study: 21870101

Group type: EXPERIMENTAL
Intervention: Alumina heads
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cobalt-chrome heads
Number of subjects: 0
Study: 20647334

Group type: EXPERIMENTAL
Intervention: School-based helmet promotion program (1-month intervention based on the Health Belief Model)
Number of subjects: 741

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 741
Study: 18922386

Group type: EXPERIMENTAL
Intervention: Camu-camu juice (70 ml daily for 7 days, 1050 mg of vitamin C)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Vitamin C tablets (1050 mg for 7 days)
Number of subjects: 20
Study: 16019622

Group type: EXPERIMENTAL
Intervention: Dietary hempseed oil
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 0
Study: 12504260

Group type: EXPERIMENTAL
Intervention: Second-generation Moroccan migrant patients
Number of subjects: 272

Group type: COMPARATOR
Intervention: Belgian patients
Number of subjects: 272
Study: 10363425

Group type: EXPERIMENTAL
Intervention: Detection of TNF-alpha activity in peritoneal fluid (PF)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Isolation of bacteria from peritoneal fluid
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Correlation of TNF-alpha with bacterial isolation
Number of subjects: 73
Study: 7794222

Group type: EXPERIMENTAL
Intervention: Tyrosine (150 mg.kg‐1 in a split dose)
Number of subjects: 2

Group type: COMPARATOR
Intervention: Cornstarch placebo
Number of subjects: 2
Study: 1951222

Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 6972026

Group type: EXPERIMENTAL
Intervention: Domperidone 10 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Domperidone 20 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Domperidone 40 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (placebo not specified)
Number of subjects: 0
Study: 29779422

Group type: EXPERIMENTAL
Intervention: Patient Portal Use (PPs)
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Qualitative feedback from participants
Number of subjects: 272
Study: 30527787

Group type: EXPERIMENTAL
Intervention: Visual registration biopsy
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: MRI/ultrasound image-fusion biopsy (SmartTarget)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Combined strategies (visual registration and image-fusion)
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Adverse events related to biopsy
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Urinary symptoms, erectile function, quality of life
Number of subjects: 129
Study: 28663267

Group type: EXPERIMENTAL
Intervention: Gadoterate meglumine (0.1 mmol/kg)
Number of subjects: 279

Group type: COMPARATOR
Intervention: Gadobutrol (0.1 mmol/kg)
Number of subjects: 279
Study: 25858239

Group type: EXPERIMENTAL
Intervention: Endovascular treatment following intravenous tissue-type plasminogen activator
Number of subjects: 656

Group type: COMPARATOR
Intervention: Intravenous tissue-type plasminogen activator alone
Number of subjects: 656
Study: 23352440

Group type: EXPERIMENTAL
Intervention: 2-week group physical training, dietary education and physiotherapy intervention
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: 2-week group intervention
Number of subjects: 251